Amount Raised
$66.4 Million
Round Type
Funding Round
DurhamBiotechnologyHealth CareGeneticsTherapeuticsInvestors
Description
On November 10, 2025, Precision BioSciences, Inc. entered into an underwriting agreement with Guggenheim Securities, LLC for an offering of its common stock. The offering includes the issuance and sale of 10,815,000 shares at a combined price of $6.14, along with accompanying warrants. The company also offered pre-funded warrants to certain investors
Quick answer
Precision BioSciences raised $66.4 Million in a Funding Round round, dated November 12, 2025. Investors: Guggenheim Securities, LLC. Precision BioSciences is based in Durham, North Carolina, United States.
- How much did Precision BioSciences raise?
- Precision BioSciences raised $66.4 Million in a Funding Round round on November 12, 2025.
- Who invested in Precision BioSciences?
- Guggenheim Securities, LLC is named as investors in this round.
- What does Precision BioSciences do?
- Precision is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller..
- Where is Precision BioSciences based and how big is it?
- Precision BioSciences is based in Durham, North Carolina, United States. Fundz records about 106 employees.
- Who are the decision-makers at Precision BioSciences?
- Fundz holds 5 contacts at Precision BioSciences, including the Chief of Staff to the CEO / Commercial Head. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Precision BioSciences that raised within 45 days of this round, from Fundz verified event records.
- AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- MAIA Biotechnology raised $1.5M on December 22, 2025.
- Rezubio Pharmaceuticals raised $20M (Series A) on December 19, 2025.
- Amphix Bio raised $13M (Seed) on December 18, 2025.
- FoRx Therapeutics raised $50M (Series A) on December 18, 2025.
Who to call at Precision BioSciences, and when
A new round usually means Precision BioSciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Precision BioSciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Precision BioSciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Precision BioSciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Precision BioSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Precision BioSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.